SCHEMBL13009986

SCHEMBL13009986

COCC1OC(n2cnc3c(N)ncnc32)C(OCOc2ccccc2)C1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 4/20 0.60
▸ NT5E P21589 1/20 0.53
▸ DNPH1 O43598 1/20 0.52
▸ PRKAB2 O43741 1/20 0.52
▸ TRPM2 O94759 1/20 0.52
▸ LDHA P00338 1/20 0.52
▸ ADRB2 P07550 1/20 0.52
▸ FBP1 P09467 1/20 0.52
▸ SRC P12931 1/20 0.52
▸ P2RY2 P41231 1/20 0.52
▸ P2RY1 P47900 1/20 0.52
▸ PRKAG1 P54619 1/20 0.52
▸ PRKAA2 P54646 1/20 0.52
▸ PDE4D Q08499 1/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ PRKAA1 Q13131 1/20 0.52
▸ PDE3A Q14432 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ TAS1R3 Q7RTX0 1/20 0.52
▸ TAS1R1 Q7RTX1 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13010017 0.93 ADORA1 (0.60) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL13009972 0.86 ADORA1 (0.55) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL21999787 0.86 ADORA1 (0.61) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL12360837 0.85 ADORA3 (0.64) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL21999233 0.85 ADORA3 (0.64) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL8626012 0.85 ADORA3 (0.64) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL12376383 0.85 ADORA3 (0.64) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL13010014 0.83 AHCY (0.53) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL21999229 0.83 AHCY (0.56) ADORA1DNPH1PRKAB2TRPM2LDHA
SCHEMBL13009985 0.82 HINT1 (0.56) NT5ETAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317714-A1 COMPLEX MOLECULE INTERFERING THE EXPRESSION OF TARGET GENES AND ITS PREPARING METHODS SUZHOU RIBO LIFE SCIENCE CO., LTD (CN) 2010-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317714-A1 COMPLEX MOLECULE INTERFERING THE EXPRESSION OF TARGET GENES AND ITS PREPARING METHODS DCLRE1B, RNASE1, AGO2 ADORA1 3979/4885NT5E 2197/4885DNPH1 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback